George Soros Net Worth and Top 5 Holdings Heading into 2023

2. Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN)

Value of Soros Fund Management‘s 13F Position: $344 million

Number of Hedge Fund Shareholders: 36

Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) climbed into second place among George Soros’ largest holdings after the billionaire’s family office raised its stake in the company by 82% during Q3, giving it over 2.27 million shares of BHVN. Hedge fund ownership of the Biohaven shot up during Q2 but fell even harder during Q3, tumbling by 40%.

Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN) is the second company among Soros’ top 3 holdings that was acquired early in the fourth quarter. In this case, Biohaven was acquired by one of the 10 Cash-Rich Stocks to Buy According to Hedge Funds, Pfizer Inc. (NYSE:PFE), which put its cash hoard to good use in the all-cash transaction valued at $11.6 billion.

Biohaven Pharmaceutical Holding Company Ltd. (NYSE:BHVN)’s calcitonin gene-related peptide (CGRP) portfolio was attractive to Pfizer given its potential to effectively treat migraine pain, which affects more than a billion people globally. Biohaven’s CGRP receptor antagonist NURTEC ODT is FDA approved for the treatment of both acute and episodic migraines in adults. The company also has an intranasal spray for migraines that is expected to receive FDA approval in the first quarter of 2023.